Literature DB >> 26344507

Hemodiafiltration: Technical and Clinical Issues.

Claudio Ronco.   

Abstract

Hemodiafiltration (HDF) seems to represent the gold standard in the field of replacement of renal function by dialysis. High convective fluxes have been correlated with better clinical outcomes. Sometimes, however, there are technical barriers to the achievement of high blood flows adequate to perform effective convective therapies. In spite of optimized procedures, the progressive increase in transmembrane pressure (TMP), the blood viscosity due to hemoconcentration and blood path resistance sometimes becomes inevitable. We propose two possible solutions that can be operated automatically via specific software in the dialysis machine: predilution on demand and backflush on demand. Predilution on demand consists in an automatic feedback of the machine, diverting part of the filtered dialysate into a predilution mode with an infusion of 200 ml in 30 s while the ultrafiltration pump stops. This produces a sudden hemodilution with a return of the parameters to acceptable values. The performance of the filter improves, and the pressure alterations are mitigated. Backflush on demand consists in an automatic feedback of the machine triggered by the TMP control, producing a positive pressure in the dialysate compartment due to a stop of filtration and rapid infusion of at least 100 ml of ultrapure dialysate into the hollow fiber. This not only produces a significant hemodilution, but also backflushes the membrane pores detaching protein layers and improving membrane permeability. These are two examples of how technology will permit to overcome technical barriers to a widespread diffusion of HDF and adequate convective dose delivery.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26344507     DOI: 10.1159/000437403

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  9 in total

1.  Anisocytosis predicts postoperative renal replacement therapy in patients undergoing heart valve surgery.

Authors:  Piotr Duchnowski; Tomasz Hryniewiecki; Mariusz Kuśmierczyk; Piotr Szymański
Journal:  Cardiol J       Date:  2019-02-25       Impact factor: 2.737

2.  Haemodiafiltration use in children: data from the Italian Pediatric Dialysis Registry.

Authors:  Fabio Paglialonga; Enrico Vidal; Carmine Pecoraro; Isabella Guzzo; Mario Giordano; Bruno Gianoglio; Ciro Corrado; Rosa Roperto; Ilse Ratsch; Salvatore Luzio; Luisa Murer; Silvia Consolo; Giovanni Pieri; Giovanni Montini; Alberto Edefonti; Enrico Verrina
Journal:  Pediatr Nephrol       Date:  2019-01-05       Impact factor: 3.714

3.  Cardiovascular Risk Comparison between Expanded Hemodialysis Using Theranova and Online Hemodiafiltration (CARTOON): A Multicenter Randomized Controlled Trial.

Authors:  Yeonhee Lee; Myoung-Jin Jang; Junseok Jeon; Jung Eun Lee; Wooseong Huh; Bum Soon Choi; Cheol Whee Park; Ho Jun Chin; Chae Lin Kang; Dong Ki Kim; Seung Seok Han; Kwon Wook Joo
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

Review 4.  Mass Transport in High-Flux Hemodialysis: Application of Engineering Principles to Clinical Prescription.

Authors:  Farzad Mohajerani; William R Clark; Claudio Ronco; Vivek Narsimhan
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-11       Impact factor: 10.614

5.  Effects of a medium cut-off (Theranova®) dialyser on haemodialysis patients: a prospective, cross-over study.

Authors:  Mario Cozzolino; Lorenza Magagnoli; Paola Ciceri; Ferruccio Conte; Andrea Galassi
Journal:  Clin Kidney J       Date:  2019-11-11

Review 6.  High-volume online haemodiafiltration treatment and outcome of end-stage renal disease patients: more than one mode.

Authors:  Helmut Schiffl
Journal:  Int Urol Nephrol       Date:  2020-06-02       Impact factor: 2.370

Review 7.  Expanded haemodialysis: from operational mechanism to clinical results.

Authors:  Claudio Ronco; Nicola Marchionna; Alessandra Brendolan; Mauro Neri; Anna Lorenzin; Armando J Martínez Rueda
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

8.  Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial.

Authors:  Lorenz Weidhase; Jonathan de Fallois; Elena Haußig; Thorsten Kaiser; Meinhard Mende; Sirak Petros
Journal:  Crit Care       Date:  2020-11-11       Impact factor: 9.097

9.  An initial evaluation of expanded hemodialysis on hospitalizations, drug utilization, costs, and patient utility in Colombia.

Authors:  Juan G Ariza; Surrey M Walton; Adriana M Suarez; Mauricio Sanabria; Jasmin I Vesga
Journal:  Ther Apher Dial       Date:  2021-01-31       Impact factor: 1.762

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.